[1]陈 姣,罗丹梅,孙承霞,等.扶正化浊法治疗动脉粥样硬化研究进展[J].陕西中医,2023,(11):1653-1656.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.039]
　CHEN Jiao,LUO Danmei,SUN Chengxia,et al.Research progress of atherosclerosis based on Fuzheng Huazhuo treatment[J].,2023,(11):1653-1656.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.039]
点击复制

扶正化浊法治疗动脉粥样硬化研究进展
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年11期
页码:
1653-1656
栏目:
综 述
出版日期:
2023-11-05

文章信息/Info

Title:
Research progress of atherosclerosis based on Fuzheng Huazhuo treatment
作者:
陈 姣; 罗丹梅; 孙承霞; 李雪萍
(成都中医药大学附属医院,四川 成都 610072)
Author(s):
CHEN Jiao; LUO Danmei; SUN Chengxia; LI Xueping
(Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610072,China)
关键词:
动脉粥样硬化;  炎症性血管病变;  扶正化浊;  浊邪;  吲哚-3-丙酸;  肠道菌群代谢
Keywords:
Atherosclerosis;  Inflammatory vascular disease;  Fuzheng Huazhuo treatment;  Zhuoxie;  Indole-3-propionic acid;  Intestinal flora metabolism
分类号:
R 543.5
DOI:
DOI:10.3969/j.issn.1000-7369.2023.11.039
文献标志码:
A
摘要:
动脉粥样硬化是一种与饮食、吸烟、肥胖等因素密切相关的,以脂质蓄积为特征的慢性炎症性血管病变,其发病率逐年上升,严重危害人类健康。在现代中医学中,浊邪既是动脉粥样硬化的病理产物又是致病因素,常易导致正虚浊成的病机,因此从扶正化浊入手治疗动脉粥样硬化尤为必要。近年来,随着对肠道菌群代谢产物吲哚-3-丙酸研究的不断加深,发现吲哚-3-丙酸的代谢与扶正化浊的治法具有一定相关性,进一步加强了吲哚-3-丙酸和动脉粥样硬化的联系,也为中医药以吲哚-3-丙酸为靶点,通过扶正化浊法干预吲哚-3-丙酸水平延缓动脉粥样硬化提供新的视角。
Abstract:
Atherosclerosis(AS)is a chronic inflammatory vascular disease characterized by lipid accumulation,which is closely related to diet,smoking,obesity and other factors.Its incidence is increasing year by year,which seriously endangers human health.In modern Chinese medicine,turbidity is not only the pathological product of atherosclerosis but also the pathogenic factor,which often leads to pathogenesis of positive deficiency turbidity.It is particularly necessary to treat atherosclerosis by righting turbidity.In recent years,with deepening of research on indole-3-propionic acid,metabolic product of intestinal flora,it has been found that the metabolism of indole-3-propionic acid has a certain correlation with treatment of Fuzheng Huazhuo,which further strengthens relationship between indole-3-propionic acid and atherosclerosis.It is also the target of indole-3-propionic acid in traditional Chinese medicine.It provides a new perspective to intervene indole-3-propionic acid level to delay atherosclerosis by Fuzheng Huazhuo.

参考文献/References:

[1] Libby P,Buring JE,Badimon L,et al.Atherosclerosis[J].Nat Rev Dis Primers,2019,5(1):56.
[2] Lusis AJ.Atherosclerosis[J].Nature,2000,407(6801):233-241.
[3] Grootaert MJ,Roth L,Schrijvers DM,et al.Defective autophagy in atherosclerosis:To die or to senesce?[J].Oxid Med Cell Longev,2018,20(18):7687083.
[4] Agus A,Planchais J,Sokol H.Gut microbiota regulation of tryptophan metabolism in health and disease[J].Cell Host Microbe,2018,23(6):716-724.
[5] 黄 琦,万 强,刘中勇.基于“浊”与氧化三甲胺相关性探讨动脉粥样硬化之病机[J].中华中医药杂志,2021,36(8):4529-4532.
[6] 唐娜娜,李 林,骆始华,等.关于浊的理论探析[J].中医药通报,2014,13(6):28-29.
[7] 李佃贵,朱 峰,刘建平,等.浊毒论治探讨[J].山西中医,2008,24(11):1-3.
[8] 蒋芙苓,于 睿.几种常用中药抗动脉粥样硬化作用[J].辽宁中医药大学学报,2014,16(2):149-151.
[9] 冯 君,刘建和,冉俊宁,等.从痰,瘀,虚探讨动脉粥样硬化的中西医病机[J].陕西中医,2020,41(2):217-219.
[10] 梁秀睿,王凤荣.基于《内经》“病在脉,调之血”论动脉粥样硬化[J].中西医结合心脑血管病杂志,2020,18(17):2919-2921.
[11] 陈龙娇,王 琦,王 济,等.从中医体质学角度建立老年健康状态管理新模式[J].中华中医药杂志,2022,37(7):3961-3965.
[12] 张会永,闵冬雨,贾连群,等.基于肠道菌群失衡探讨脾病“脉道不利”的科学内涵[J].中华中医药杂志,2019,34(11):5150-5153.
[13] Bartolomaeus H,Balogh A,Yakoub M,et al.Short-chain fatty acid propionate protects from hypertensive cardiovascular damage[J].Circulation,2019,139(11):1407-1421.
[14] Rodriguez MJ,Matthan NR.Nutrition and gastrointestinal microbiota microbial-derived secondary bile acids and cardiovascular disease[J].Curr Atheroscler Rep,2020,22(9):47.
[15] Konopelski P,Ufnal M.Indoles-gut bacteria metabolites of tryptophan with pharmacotherapeutic potential[J].Curr Drug Metab,2018,19(10):883-890.
[16] 刘 涛,欧阳林旗,陈 镇,等.中药调控色氨酸-肠道菌群代谢治疗溃疡性结肠炎的研究进展[J].湖南中医药大学学报,2022,42(2):324-331.
[17] 苟小军,杨 艳,杨晓露,等.色氨酸代谢研究进展[J].医学研究杂志,2021,50(3):126-128.
[18] 王丽群,庞日朝,胡晓敏,等.肠道菌群对色氨酸代谢的影响研究进展[J].中国比较医学杂志,2021,31(4):129-136.
[19] 郭春丽,徐辉辉,师淑君,等.内源性活性物质2,3-吲哚醌抗前列腺增生作用[J].医药导报,2018,37(5):509-511.
[20] Rothhammer V,Mascanfroni ID,Bunse L,et al.Type-1 interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor[J].Nat Med,2016,22(6):586-597.
[21] Li Y,Xu W,Zhang F,et al.The gut microbiota-produced Indole-3-propionic acid confers the antihyperlipidemic effect of mulberry derived 1-Deoxynojirimycin[J].Msystems,2020,5(5):154-160.
[22] Mercer KE,Yeruva L,Pack L,et al.Xenometabolite signatures in the UC davis type-2 diabetes mellitus rat model revealed using a metabolomics platform enriched with microbe-derived metabolites[J].Am Journal Physiol Gastrointest Liver Physiol,2020,319(2):157-169.
[23] Wikoff WR,Anfora AT,Liu J,et al.Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites[J].Proc Natl Acad Sci,2009,106(10):3698-3703.
[24] Dodd D,Spitzer MH,Van TW,et al.A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites[J].Nature,2017,551(7682):648-652.
[25] Rosas HD,Doros G,Bhasin S,et al.A systems-level misunderstanding:The plasma metabolome in Huntington's disease[J].Ann Clin Transl Neurol,2015,2(7):756-768.
[26] Elsden SR,Hilton MG,Waller JM.The end products of the metabolism of aromatic amino acids by clostridia[J].Arch Microbiol,1976,107(3):283-288.
[27] Roager HM,Licht TR.Microbial tryptophan catabolites in health and disease[J].Nat Commun,2018,9(1):3294.
[28] Lamas B,Richard ML,Leducq V,et al.Card-9 impacts colitis by altering gut microbiota metabolism of tryptophan into Ary-l hydrocarbon receptor ligands[J].Nat Med,2016,22(6):598-605.
[29] Jennis M,Cavanaugh CR,Leo GC,et al.Microbiota-derived tryptophan indoles increase after gastric bypass surgery and reduce intestinal permeability in vitro and in vivo[J].Neurogastroenterol Motil,2018,30(2):352-360.
[30] Cason CA,Dolan KT,Sharma G,et al.Plasma microbiome-modulated indole and pheny-l derived metabolites associate with advanced atherosclerosis and postoperative outcomes[J].J Vasc Surg,2018,68(5):1552-1562.
[31] Xue H,Chen X,Yu C,et al.Gut microbially produced Indole-3-propionic acid inhibits atherosclerosis by promoting reverse cholesterol transport and its deficiency is causally related to atherosclerotic cardiovascular disease[J].Circ Res,2022,131(5):404-420.
[32] Gesper M,Nonnast AH,Kumowski N,et al.Gut-derived metabolite Indole-3-propionic acid modulates mitochondrial function in cardiomyocytes and alters cardiac function[J].Front Med,2021,65(8):648259.
[33] Yisireyili M,Takeshita K,Saito S,et al.Indole-3-propionic acid suppresses indoxyl sulfate-induced expression of fibrotic and inflammatory genes in proximal tubular cells[J].Nagoya Journal Med Sci,2017,79(4):477-486.
[34] Karbownik M,Stasiak M,Zygmunt A,et al.Protective effects of melatonin and indole-3-propionic acid against lipid peroxidation caused by potassium bromate in the rat kidney[J].Cell Biochem Funct,2006,24(6):483-489.
[35] Zhao ZH,Xin FZ,Xue Y,et al.Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats[J].Exp Mol Med,2019,51(9):1-14.
[36] Sehgal R,Ilha M,Vaittinen M,et al.Indole-3-propionic acid a gut-derived tryptophan metabolite associates with hepatic fibrosis[J].Nutrients,2021,13(10):458-463.
[37] Xie Y,Zou X,Han J,et al.Indole-3-propionic acid alleviates ischemic brain injury in a mouse middle cerebral artery occlusion model[J].Exp Neurol,2022,35(3):114081.
[38] Serger E,Luengo GL,Chadwick JS,et al.The gut metabolite Indole-3 propionate promotes nerve regeneration and repair[J].Nature,2022,607(7919):585-592.
[39] Man B,Hu C,Yang G,et al.Berberine attenuates diabetic atherosclerosis via enhancing the interplay between KLF16 and PPAR-α in ApoE(-/-) mice[J].Biochem Biophys Res Commun,2022,62(4):59-67.

相似文献/References:

[1]王清亮,陆文杰,陈咸川.益气活血化痰通络方对颈动脉粥样硬化患者T细胞亚群影响的研究[J].陕西中医,2019,(3):307.
　WANG Qingliang,LU Wenjie,CHEN Xianchuan..Effect of Yiqi Huoxue Huatan Tongluo formula on Tcells subset in patients with carotid atherosclerosis[J].,2019,(11):307.
[2]陈 静,陈 炜,伍 媛,等.小续命汤及其组分治疗急性脑梗死研究进展*[J].陕西中医,2019,(12):1818.
[3]冯 君,刘建和,冉俊宁,等.从痰、瘀、虚探讨动脉粥样硬化的中西医病机*[J].陕西中医,2020,(2):217.
　FENG Jun,LIU Jianhe,RAN Junning,et al.Discussion on the pathogenesis of atherosclerosis from phlegm,blood stasis and asthenia[J].,2020,(11):217.
[4]秦 魏,邢 露,杨智慧,等.丹参活性成分在抗动脉粥样硬化中的作用与机制研究进展[J].陕西中医,2021,(7):977.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.044]
[5]蔡 婉,周 华,葛 文,等.清脂化瘀颗粒调控Keap-1/Nrf2/ARE介导的氧化损伤抗动脉粥样硬化的作用及机制研究[J].陕西中医,2022,(2):166.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.006]
　CAI Wan,ZHOU Hua,GE Wen,et al.Effect and mechanism of Qingzhi Huayu granule on regulating Keap-1/Nrf2/ARE mediated oxidative damage and anti atherosclerosis[J].,2022,(11):166.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.006]
[6]陈抒鹏,王思梦,唐娜娜,等.基于浊邪与铁死亡相关性探析动脉粥样硬化之病机[J].陕西中医,2022,(11):1589.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.023]
　CHEN Shupeng,WANG Simeng,TANG Nana,et al.Exploring the pathogenesis of atherosclerosis based on the correlation between turbid pathogens and ferroptosis[J].,2022,(11):1589.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.023]
[7]Nguyen Xuan Huynh(越南),梁 硕,孟 毅,等.益气活血清热解毒方治疗动脉粥样硬化临床研究[J].陕西中医,2023,(6):746.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.014]
　Nguyen Xuan Huynh,LIANG Shuo,MENG Yi,et al.Clinical study of Yiqi Huoxue Qingre Jiedu recipe in the treatment of atherosclerosis[J].,2023,(11):746.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.014]
[8]黄昌锐,李汶珊,袁 惠,等.护心康片对动脉粥样硬化小鼠自噬干预机制[J].陕西中医,2023,(7):854.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.006]
　HUANG Changrui,LI Wenshan,YUAN Hui,et al.Intervention mechanism of cardiac protection tablets on autophagy in atherosclerotic mice[J].,2023,(11):854.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.006]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(8217153243); 四川省科技厅科研项目(2022YFS0381)
更新日期/Last Update: 2023-11-09